Nanoform Finland (STU:4YL) Total Liabilities: €10.96 Mil (As of Mar. 2026)

What is Nanoform Finland Total Liabilities?

Nanoform Finland STU:4YL -1.32% 67 Total Liabilities is €10.96 Mil as of Mar. 2026. GuruFocus rates STU:4YL with a GF Score™ of 67/100 and a GF Value™ of €1.77 (Possible Value Trap). The stock has 4 warning signs investors should review.

Nanoform Finland's Total Liabilities for the quarter that ended in Mar. 2026 was €10.96 Mil.

Nanoform Finland's quarterly Total Liabilities declined from Sep. 2025 (€12.56 Mil) to Dec. 2025 (€11.20 Mil) and declined from Dec. 2025 (€11.20 Mil) to Mar. 2026 (€10.96 Mil).

Nanoform Finland's annual Total Liabilities increased from Dec. 2023 (€11.19 Mil) to Dec. 2024 (€11.77 Mil) but then declined from Dec. 2024 (€11.77 Mil) to Dec. 2025 (€11.20 Mil).

Nanoform Finland Total Liabilities Related Terms

Nanoform Finland Total Liabilities Historical Data

* Premium members only.

The historical data trend for Nanoform Finland's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nanoform Finland Total Liabilities Chart

Nanoform Finland Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Total Liabilities

Get a 7-Day Free Trial

14.86

13.43

11.19

11.77

11.20

Nanoform Finland Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Total Liabilities	Get a 7-Day Free Trial															11.58	12.98	12.56	11.20	10.96

67GF Score

Nanoform Finland PLC STU:4YL

Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Nanoform Finland Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Nanoform Finland's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	6.146	+	(4.885	+	0.169
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	11.20

Total Liabilities	=	Total Assets (A: Dec. 2025 )	-	Total Equity (A: Dec. 2025 )
	=	53.976	-	42.776
	=	11.20

Nanoform Finland's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	5.932	+	(4.98	+	0.050999999999998
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	10.96

Total Liabilities	=	Total Assets (Q: Mar. 2026 )	-	Total Equity (Q: Mar. 2026 )
	=	50.708	-	39.745
	=	10.96

Frequently Asked Questions Learn more about Total Liabilities →

What does a Total Liabilities of €10.96 Mil mean?

Nanoform Finland (STU:4YL) has a Total Liabilities of €10.96 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Nanoform Finland and its competitors.

Is Nanoform Finland's Total Liabilities too high?

Nanoform Finland's current Total Liabilities is €10.96 Mil. Overall, Nanoform Finland has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Nanoform Finland's Total Liabilities compare to VRTX and REGN?

Nanoform Finland's Total Liabilities of €10.96 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Liabilities for a Biotechnology company?

A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Liabilities mean?

A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Nanoform Finland and its competitors. Nanoform Finland's current Total Liabilities is €10.96 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Nanoform Finland stock overvalued right now?

Based on GuruFocus' analysis, Nanoform Finland (STU:4YL) is currently considered Possible Value Trap. The stock's GF Value™ is €1.77, compared to a current price of €0.75 — trading 57.7% below its estimated fair value. The current Total Liabilities is €10.96 Mil. Nanoform Finland's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Liabilities calculated?

Total Liabilities is calculated from a company's financial statements. For Nanoform Finland (STU:4YL), the current Total Liabilities is €10.96 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nanoform Finland (STU:4YL) Overvalued in 2026?

Based on GuruFocus' analysis, Nanoform Finland stock appears to be undervalued. The current stock price of €0.75 is trading 57.7% below its estimated GF Value™ of €1.77. GuruFocus considers Nanoform Finland to be Possible Value Trap.

Key valuation signals for STU:4YL:

Total Liabilities: €10.96 Mil
GF Value™: €1.77 vs. price of €0.75 (57.7% below fair value)
GF Score™: 67/100 with 4 warning signs

No single metric tells the full story. See the STU:4YL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nanoform Finland Business Description

Industry Healthcare Biotechnology

Comparable Companies OHEL:HRTIS VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA XKRX:068270 RPRX ROIV BNTX INCY INSM HKSE:02269 ASND HKSE:01801

Other Exchanges NANOFS:Sweden NANOFH:Finland 4YL:Germany

Address Cultivator II, Viikinkaari 4, Helsinki, FIN, 00790

Website https://www.nanoform.com

Nanoform Finland PLC is a nanoparticle medicine-enabling company. The company works together with pharma and biotech partners to reduce attrition in clinical trials and enhance their molecules' formulation performance through its nano-forming services. Its patented and scalable Controlled Expansion of Supercritical Solutions (CESS) technology produces nano-formed API particles as small as 10nm. This enables poorly soluble molecules in the pharmaceutical pipeline to progress into clinical development by increasing their rate of dissolution and improving their bioavailability. Its technology provides novel opportunities in many value-enhancing drug delivery applications. Geographically, the company generates maximum revenue from Europe, followed by the United States and other regions.

67GF Score

Get the complete analysis for STU:4YL

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.75

Price

€1.77

GF Value

View STU:4YL Analysis

See Total Liabilities data for all stocks →